Osteoteri (Teriparatide)

Teriparatide, the active ingredient in Osteoteri, is a peptide hormone presented as a unknown/unknown for subcutaneous injection use. It treats osteoporosis in postmenopausal women and men at high risk of fracture. GNH USA supplies Osteoteri as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Osteoteri as a licensed, GDP‑compliant international pharmaceutical supplier serving  hospitals  pharmacy  and  clinics  worldwide.

Osteoteri is a bone‑building      ​    ​   ​  ​   ​  ​    ​   …   ... … … … … … … … … … …

-  ​     ...  ... … ... ... … ... … ... … … ... … ... … … ... ... ...